Syncrosome invites you to visit us at Neuroconnection in Marseille the 1st and 2nd July.
In the framework of the European project NeuroRescue, this symposium is an European event around technological innovation and private-public partnerships in NEUROSCIENCES and AGEING.
It will be the occasion to discuss and share experience in Neurodegenerative diseases and more precisely in Parkinson field.
During this symposium our experts would be delighted to meet you and give you advice about o...
In June, we participated to the 4th Drug Development Summit in Switzerland and one of
our objective was to collect new information on the way to conduct R&D in the Pharmaceutical industry, Biotech. companies and also the management of pre-clinical R&D.
During this congress we had more than 25 Face-to-Face meetings with big pharma like Novartis, Sanofi, UCB and also Biotech and mid-size pharma like Helsinn, ADDEX… It is an important congress for us to have a feedback from o...
Syncrosome is a Preclinical Drug Evaluation Company specialised in human and animal health in vivo pharmacological studies. Syncrosome has the professional expertise to complete studies independently or to work in parallel with in-house research teams, after preliminary in vitro screenings - www.syncrosome.com